Farms.com Home   News

SHIC Requests Pork Sector Input for Its 2023 Plan of Work

The Swine Health Information Center is requesting broad input from industry as it formulates the Plan of Work that will guide its activities during the coming year.
As part of its December eNewsletter the Swine Health Information Center has issued an invitation to pork sector stakeholders to outline priorities and submit ideas for dealing with emerging swine health issues.
SHIC Executive Director Dr. Paul Sundberg notes the plan of work provides a framework of what producers consider important in addressing emerging issues.

Clip-Dr. Paul Sundberg-Swine Health Information Center:
The 2022 plan of work is on the swinehealth.org web site so people can see that as an example of what we're looking for.
We try to start with a blank slate every year but we look at things like improving information, like responding to disease, to emerging disease, things like ensuring there are diagnostics to discover emerging diseases.
There are broad headings that we try to work under.
What we're asking is for researchers, university researchers or other researchers, allied industries, pork producers especially, veterinarians and also state and federal animal health officials to give us input into the things that are on their minds about emerging diseases and their priorities for what needs to happen in the next 12 months.
We don't do this plan of work as a five-year plan.
We do it every year because we want to work urgently and nimbly to make sure that we get at the things that are affecting or are on the high priority list of the industry currently so we can make progress and help to strengthen the pork industry.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.